Trial Profile
Abatacept Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project: An Extension Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 24 Jul 2023
Price :
$35
*
At a glance
- Drugs Abatacept (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 23 May 2022 Status changed from recruiting to completed.
- 26 Mar 2018 Planned End Date changed from 31 Dec 2018 to 31 Dec 2019.
- 26 Mar 2018 Planned primary completion date changed from 31 Dec 2018 to 31 Dec 2019.